Publication Ethics
Publication Ethics
Journal of Clinical Microbiology and Infectious Diseases (JCMID) is committed to upholding the highest standards of research integrity, transparency, and ethical conduct in every aspect of academic publication.
Overview
JCMID adheres to the ethical principles established by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council for International Organizations of Medical Sciences (CIOMS), and the Declaration of Helsinki. All parties — authors, reviewers, and editors — are expected to understand and uphold these standards.
Research involving human participants must comply with the Declaration of Helsinki (2013) and applicable national regulations, including approval by a recognised ethics committee or Institutional Review Board (IRB/KEPK). Research involving animals must follow ARRIVE 2.0 guidelines. JCMID may request proof of ethical approval at any stage of the review or post-publication process.
AI in Research & Publication
In accordance with COPE (2023) and ICMJE (2023) guidelines on AI and AI-assisted technologies
Permitted Use
- Grammar and spell-checking assistance
- Language editing and translation support
- Summarising or organising author-generated content
- Statistical software and bioinformatics pipelines with appropriate citation
- Image processing tools (non-manipulative, with disclosure)
Not Permitted
- Listing AI tools as authors (AI cannot hold authorship responsibility)
- Generating original scientific data, results, or conclusions via AI
- Using AI to fabricate, falsify, or misrepresent research findings
- Submitting AI-generated text without disclosure as original work
- Circumventing plagiarism detection or peer review via AI
Disclosure requirement: Authors must declare all AI tools used in the Methods section or Acknowledgements. The corresponding author is solely responsible for the accuracy and integrity of AI-assisted content. AI-generated images or figures must be explicitly identified in the figure legend.
Human and Animal Research Rights
Human Participants
All research involving human subjects must have prior approval from a recognised ethics committee or IRB (Komite Etik Penelitian Kesehatan / KEPK in Indonesia). Authors must state the name of the ethics committee, approval number, and date in the Methods section.
Written informed consent must be obtained from all participants. For retrospective or anonymised data, a waiver statement from the ethics committee is required.
Animal Subjects
Studies involving animals must comply with relevant national and institutional guidelines, and adhere to the ARRIVE 2.0 (Animal Research: Reporting of In Vivo Experiments) guidelines. Ethics committee approval for animal use must be disclosed.
Authors must describe measures taken to minimise animal suffering and confirm that experiments were designed following the 3Rs principle (Replacement, Reduction, Refinement).
Patient Confidentiality
Patient anonymity must be strictly maintained. Identifying information (names, hospital IDs, images) must be removed or masked unless explicit written consent for publication has been obtained. Case reports must include a signed patient consent statement.
Biosafety, Biosecurity, and Dual-Use Research
Given JCMID's focus on clinical microbiology and infectious diseases, authors working with potentially dangerous pathogens, toxins, or infectious agents are subject to additional ethical obligations.
Biosafety Level Disclosure
Authors must declare the Biosafety Level (BSL-1 to BSL-4) of all pathogens used and confirm that experiments were conducted in appropriately certified laboratory facilities. Institutional biosafety committee (IBC) approval must be stated in the Methods section.
Select Agents & Regulated Pathogens
Research involving Select Agents, Category A–C bioterrorism agents (CDC/NIAID classification), or nationally regulated pathogens (Permenkes RI) requires explicit regulatory approval. Authors must confirm compliance and identify the approving authority.
Dual-Use Research of Concern (DURC)
JCMID follows the WHO DURC policy (2013). Research that could be misused to pose a threat to public health, safety, or national security — including enhanced pathogen transmissibility, virulence, or antimicrobial resistance — must be reviewed by the authors' Institutional DURC Review Committee prior to submission.
Pathogen & Sequence Data Sharing
Nucleotide and protein sequences must be deposited in GenBank/NCBI, GISAID (for influenza and SARS-CoV-2), or equivalent public repositories prior to submission. Accession numbers must appear in the manuscript. Embargoes may be considered only in documented regulatory or security circumstances.
Editor's right of refusal: The editors reserve the right to reject or require modification of any manuscript where biosafety, biosecurity, or DURC obligations cannot be verified, or where publication is judged to pose an unacceptable public health risk, in consultation with institutional and regulatory experts.
Responsibilities by Role
Editors
- Make fair, unbiased editorial decisions based solely on scientific merit and scope
- Ensure a rigorous, double-blind peer review process
- Maintain confidentiality of submitted manuscripts and reviewer identities
- Disclose and manage conflicts of interest; recuse from decisions involving COI
- Investigate all allegations of misconduct promptly and thoroughly
- Issue corrections, expressions of concern, or retractions per COPE guidelines
- Protect the integrity of the published record at all times
Reviewers
- Review manuscripts promptly and provide constructive, objective feedback
- Decline review if there is any potential conflict of interest
- Maintain strict confidentiality; not share or disclose any part of the manuscript
- Not use unpublished information or ideas for personal advantage
- Alert editors to substantial similarity with other published work
- Identify relevant published work not cited by the authors
- Complete reviews within the agreed timeframe or notify the editor promptly
Authors
- Ensure originality of work; not submit to multiple journals simultaneously
- Accurately report methods, data, and results; not fabricate or falsify
- Properly attribute all sources and obtain permission for reproduced material
- Disclose all conflicts of interest, funding sources, and sponsorships
- Include all and only those who meet ICMJE authorship criteria
- Obtain and document ethics approval and informed consent
- Notify the editor promptly of any significant errors discovered post-submission
Specific Ethical Standards
Reporting Standards
Authors must follow applicable reporting guidelines: CONSORT (RCTs), STROBE (observational studies), PRISMA (systematic reviews/meta-analyses), CARE (case reports), STARD (diagnostic accuracy), and ORION/IDSA (outbreak reports). Reporting checklists must be submitted as supplementary files. AST data must follow EUCAST or CLSI breakpoint standards with version cited.
Originality & Attribution
Submitted manuscripts must be original and must not be published or under review elsewhere. All sources of data, ideas, and text must be properly attributed. JCMID uses plagiarism detection software; a similarity index above 20% (excluding references and quoted material) will prompt editorial review. Self-plagiarism, including duplicate submission of the authors' own previously published data, is not permitted without prior approval and explicit disclosure.
Multiple & Redundant Publication
Manuscripts submitted to JCMID must not be simultaneously under consideration by another journal. If the work has been presented at a conference, the authors must disclose this. Redundant publication — submitting the same data in different forms or languages without cross-referencing — is considered a breach of ethics and may result in retraction and notification to the authors' institutions.
Authorship Criteria
Authorship must comply with ICMJE criteria: (1) substantial contribution to conception/design or data acquisition/analysis; (2) drafting or critically revising the manuscript; (3) approving the final version; and (4) accountability for all aspects of the work. All authors must submit a CRediT (Contributor Roles Taxonomy) statement. Guest authorship, ghost authorship, and coercive citation are not permitted and are treated as misconduct.
Image & Data Integrity
Figures, micrographs, gel images, chromatograms, and sequencing outputs must accurately represent the original data. Contrast or brightness adjustments must be applied to the entire image uniformly, with disclosure in the figure legend. Selective manipulation, splicing, or artificial enhancement to misrepresent results constitutes research misconduct. JCMID may request original, unprocessed data files at any stage.
Hazardous Materials
Research involving chemical, biological, radioactive, or other hazardous materials must confirm compliance with all applicable safety regulations. Authors must state that appropriate containment, disposal, and safety protocols were followed. Clinical specimens and infectious agents must be handled per WHO Laboratory Biosafety Manual (4th ed.) and institutional guidelines.
Errors in Published Works
Authors who discover significant errors in their published work must promptly notify the JCMID editorial office. JCMID will publish a Correction for minor errors, an Expression of Concern when an investigation is ongoing, or a Retraction per COPE Retraction Guidelines if the findings are unreliable due to misconduct or honest error. All notices are linked to the original article and permanently indexed.
Changes to Authorship
Any change to the author list — additions, removals, or reordering — after submission requires written explanation and the signed consent of all listed authors, including any author being removed. Such changes are subject to editorial review and approval. Changes requested after acceptance will require extraordinary justification and may delay publication.
Submission Declaration & Conflicts of Interest
By submitting to JCMID, authors confirm that the work is original, has not been published elsewhere, and is not under simultaneous consideration by another journal. All potential conflicts of interest — including financial relationships with pharmaceutical companies, diagnostics manufacturers, commercial laboratories, or funding bodies — must be disclosed in the manuscript and in the submission system. Funding sources must be acknowledged in the Acknowledgements section.
Handling of Alleged Misconduct
JCMID takes all allegations of research or publication misconduct seriously and follows COPE flowcharts and guidelines in handling suspected cases. Allegations may be reported to the editorial office at editorial@jcmid.id. All reports will be treated confidentially during investigation.
Useful Resources
JCMID's publication ethics framework is aligned with internationally recognised standards and guidelines.
For ethics-related inquiries, contact: editorial@jcmid.id